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The native one-chain tissue plasminogen activator fr m the human melanoma cell line (Bowes) occurs in 
two variants as demonstrated bysodium dodecylsulphate-polyacrylamide gel electrophoresis of reduced 
and carboxymethylated samples. The two variants were isolated by affinity chromatography on arginine- 
Sepharose using a uanidinium-HC1 gradient, in the order of elution, the variants were designated tissue 
plasminogen activator I and I. Variant I was found to be 3000 Mr larger than variant II and the difference 
was found to reside in the N-terminal half of the molecule. No substantial difference i  carbohydrate 
content nor in enzymatic activity was demonstrated. 
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1. INTRODUCTION 
Here, two variants of native one-chain tissue 
plasminogen activator (tissue PA) have been iso- 
lated; their difference is shown to reside in the N- 
terminus. The isolation procedure works equally 
well with reduced and carboxymethylated prepa- 
rations and provides a convenient method for the 
isolation of electrophoretically homogenous prepa- 
rations corresponding to the A and B chains of 
two-chain tissue PA. 
Tissue PA can be extracted from most tissue ho- 
mogenates [1]. It is similar or identical to the vas- 
cular activator and the activator of the extrinsic 
fibrinolytic pathway [2]. Native tissue PA (Mr 
- 70 000) is a one-chain polypeptide and has been 
shown by amino acid and cDNA sequence analysis 
to be homologous to serine protease zymogens 
[3,4]. However, native one-chain tissue PA is an ac- 
tive serine protease [5-7]. This irregularity is re- 
flected in (or perhaps due to) a lysine residue at a 
position in the activation cleavage site region 
( -Arg&I le -Lys -G ly -G ly - )  that typically har- 
bours a hydrophobic residue [8]. 
When digested with plasmin either in purified 
systems [5] or in fibrin clots [6] the native one- 
chain activator is transformed into a two-chain 
form by cleavage at the zymogen activation site 
[3,4]. The two disulfide connected chains of Mr 
-40 000 and 30 000 are designated A and B, re- 
spectively [3,5]. The B chain originates from the C- 
terminal of one-chain tissue PA and is homologous 
to trypsin [3]. In the presence of fibrin one-chain 
and two-chain tissue PA have similar enzymatic 
properties [6,7], but in the absence of fibrin the 
two-chain form is generally 2-10-fold more effi- 
cient [5,7,9,10]. 
Electrophoretic analysis of reduced and car- 
boxymethylated preparations of two-chain tissue 
PA from a human melanoma cell line show that 
the A chain (the N-terminal part of one-chain mol- 
ecule) exists in two variants with apparent Mr-val- 
ues of 40 000 and 37 000 [3]. 
2. MATERIALS AND METHODS 
Culture medium from confluent human melano- 
ma cells [11,12] sustained [3] on modified Eagle's 
minimal essential medium containing 50 KIU/ml 
aprotinin was the source of tissue PA. Immunoglo- 
bulins against porcine tissue PA were isolated from 
goat antiserum and immobilized on Sepharose 4B 
as in [3,5]. Fibrinolytic activity was measured with 
a clot lysis method using a urokinase standard 
(code no. 66/46, WHO International Laboratory 
for Biological Standards, Holly Hill, Hampstead). 
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Reduction with dithioerythritol and carboxymeth- 
ylation with iodo-acetic acid was performed as in 
[3]. Sodium dodecylsulphate-polyacrylamide gel 
electrophoresis (SDS-PAGE) analysis was per- 
formed [13] on 7% polyacrylamide gels using an 
Mr calibration kit. Protein content was determined 
by amino acid analysis [14]. Carbohydrate content 
was determined with anthrone [15] using a multi- 
ple standard addition method on lyophilized G- 
150 purified samples. A 1:1 mixture of D-galac- 
tose/D-mannose was used as standard and non- 
protein containing G-150 eluate as blank. Neur- 
aminidase (Clostridium perfringens, type VIII, Sig- 
ma, St Louis MO) treatment was in 0.5 M sodium 
acetate buffer (pH 4.5) [17]. Aminolytic activity 
was determined [5] on D-Va l -G ly -Arg-pNA and 
D- I le-Pro-Arg-pNA (S-2322 and S-2288, cour- 
tesy of Dr Petter Friberger, Kabi Peptide Re- 
search, MSlndal). Arginine-Sepharose was pre- 
pared in the same way as lysine-Sepharose [16]. 
Sepharose 4B, G-150 and the Mr calibration kit 
were purchased from Pharmacia (Uppsala), the 
non-ionic detergent Tween 80 from Kebo (Stock- 
holm) and aprotinin (Trasylol R) from Bayer 
(Leverkusen). 
3. RESULTS 
3.1. One-chain tissue PA I  and H 
Tissue PA was purified from 50 I melanoma cell 
culture medium by affinity chromatography on 
90 g anti-porcine tissue PA immunoglobulin- 
Sepharose [3,5]. The activator activity (in 3 M 
KSCN) was diluted 20-fold with 0.1 M NH4HCO 3, 
0.1 g/1 Tween 80, applied to an argi- 
nine-Sepharose column and eluted with a linear 
guanidinium gradient. The activity eluted in 2 par- 
tially separated peaks (designated I and II in order 
of their appearance) as shown in fig. 1. Pooled frac- 
tions (each containing -4  mg tissue PA) were con- 
centrated to - 15 ml and separately gel filtered on 
G-150 columns (5 cm 2 x 80 cm) equilibrated with 
1 M NH4HCO3, 0.1 g/1Tween 80. 
SDS-PAGE of reduced and carboxymethylated 
samples of one-chain tissue PA I  and II mixtures 
resolved 2 closely-spaced bands (seen as a broad 
band in fig.2). 
3.2. Two-chain tissue PA I and H 
About 1 mg of one-chain tissue PA I or II dis- 
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Fig.1. Arginine-Sepharose chromatography of 3 x l06 
IU ( -  14 mg) immunosorbent purified one-chain tissue 
PA. The preparation was dissolved in 100 ml 0.1 M 
NH4HCO3, 0.15 M KSCN and applied to a column (5 
cm 2 x 6 cm) of arginine-Sepharose. The column was 
washed with 50 ml 0.1 M NH4HCO3 and adsorbed ma- 
terial eluted with a linear guanidinium-HC1 gradient 
(mixing vessel, 300 ml 0.1 M NH4HCO3; limiting vessel, 
300 ml 0.1 M NH4HCO 3, 0.7 M guanidinium-HC1). 
The chromatography was performed at 4°C and 30 ml/ 
h. All solvents contained 25 KIU/ml aprotinin and 0.1 
g/l Tween 80. The absorbance at 280 nm ( - - )  was con- 
tinuously monitored and the fibrinolytic activity (o--o) 
was pooled as indicated by the vertical lines 
(310 - 430 ml, variant I; 500 - 590 ml, variant II). 
solved in 2 ml 1 M ammonium bicarbonate, 0.1 g/l 
Tween 80 was digested with 15 mg plasmin- 
Sepharose (containing 0.1 mg plasmin) as in [5]. 
SDS-PAGE analysis of reduced and carboxy- 
methylated samples (fig.2) showed that one-chain 
tissue PA I  and II both were quantitatively con- 
verted to the two-chain form. The B chains of the 
activator variants I and II were apparently identi- 
cal, but the A chains showed a size difference of 
-3000 Mr. The apparent Mr-values of the A 
chains were 40 000 and 37 000 for two-chain tissue 
PA variants I and II, respectively. The difference 
did not disappear on neuraminidase treatment of 
the two-chain activator prior to reduction and car- 
boxymethylation. 
Two-chain tissue PA variants I and II chro- 
matographed in the same way as the one-chain 
variants on arginine-Sepharose. When reduced 
and carboxymethylated samples of two-chain 
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The specific fibrinolytic activity was 240 000 and 
260 000 IU/mg for one-chain tissue PA I and II 
and 210000 and 240000 IU/mg for two-chain 
tissue PAI  and II. The amidolytic activity on 0.4 
mM D-VaI -Gly-Arg-pNA (S-2322) at 25°C in 
0.1 M NaC1, 0.05 Tris (pH 7.5) expressed in AA405/ 
min for 1 /~g enzyme/ml was 0.0089, 0.0069, 0.058 
and 0.049 for one-chain tissue PA I  and II and 
two-chain tissue PA 1 and II. The corresponding 
values on D-I le-Pro-Arg--pNA (S-2288) were 
0.0096, 0.012, 0.056 and 0.062. All determinations 
were performed in triplicate and the standard e- 
viation never exceeded 5%. 
Fig.2. SDS-PAGE analysis of reduced and carboxy- 
methylated samples of tissue PA purified by immu- 
nosorbent, arginine-Sepharose and G-150 chroma- 
tography. Two-chain tissue PA was prepared by in vitro 
digestion of one-chain tissue PA with plasmin-- 
Sepharose: (a) mixture of one-chain tissue PA variants I 
and II; (b) mixture of two-chain tissue PA variants I and 
II; (c) two-chain tissue PA I; (d) two-chain tissue PA II. 
tissue PA were chromatographed, the A chains 
were found to bind to the gel and to elute with the 
guanidinium gradient (not shown). 
3.3. Carbohydrate content and enzymatic properties 
Variants I and II of one-chain tissue PA con- 
tained 6.9 and 6.7% (w/w) carbohydrates, respec- 
tively. The difference is not significant since the 
standard eviation was 0.7% for both determina- 
tions. 
4. DISCUSSION 
Two variants of one-chain tissue PA were iso- 
lated by affinity chromatography on arginine- 
Sepharose using a uanidinium gradient. Variant I
eluted first. The difference was found to reside in 
the N-terminal part of the molecule (A chain of 
the two-chain tissue PA). Two-chain tissue PA I  
and II, and to our surprise, reduced and carboxy- 
methylated A chain variants behaved in the same 
way as one-chain tissue PA on arginine- 
Sepharose, When analysed on SDS-PAGE the A 
chain variants I and II had apparent Mr-values of 
40 000 and 37 000, respectively. This does not indi- 
cate differences in sialic acid content since neur- 
aminidase treatment did not change the SDS-  
PAGE results. No significant difference in carbo- 
hydrate content and no substantial difference in 
fibrinolytic nor amidolytic activity between the 
variants was observed. 
Plasmin digestion f one-chain tissue PA I re- 
sults in a two-chain activator with homogenous A 
chain. This rules out that the A chain hetero- 
geneity observed in [3] is due to partial removal of 
a terminal 3000 Mr peptide. 
It is tempting to speculate that the two variants 
of tissue PA are correlated physiologically to the 
plasminogen variants I and II (isolated in a similar 
manner) [18]. Plasminogen I and II occur in many 
mammalian species [19] indicating a physiological 
function yet to be unraveled. 
The findings presented here may be of impor- 
tance for cDNA work on tissue PA. Studies on the 
genetic origin (two alleles or two loci), physiologi- 
cal functions (thrombolysis and turn-over), in vitro 
kinetics and sequence analysis are in progress. 
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